SARS-CoV-2 Myocarditis Diagnostic Probability (Troponin + MRI + ECG)

Clinical calculation support · Verify results before clinical use

Clinical findings

Enter the available findings to display the original heuristic point total.

Not a validated score
Enter the peak value divided by the assay-specific upper reference limit. This is not an absolute concentration.
Select the most appropriate description; these categories are supportive findings and are not specific for myocarditis.
Use the CMR report and the clinical context. Lake Louise criteria support myocardial inflammation; they do not establish SARS-CoV-2 as the cause.
Enter a whole number when CMR was performed. Leave blank if CMR was not performed.
Reset calculator

Clinical context and limitations

Troponin indicates myocardial injury, not its cause. ECG abnormalities may support suspicion but are not specific. CMR using the revised 2018 Lake Louise Criteria can provide evidence of myocardial inflammation when a T2-based marker of edema and a T1-based marker of myocardial injury are present in an appropriate clinical setting.

Neither troponin elevation nor CMR alone proves that inflammation is caused by SARS-CoV-2. Consider the full clinical presentation and competing diagnoses, including acute coronary syndrome, MINOCA, pericarditis, stress cardiomyopathy, other infectious or immune-mediated myocarditis, and non-inflammatory myocardial injury.

How to interpret this tool

  • The displayed points reproduce the supplied heuristic, not a validated clinical prediction rule.
  • No patient-level probability, sensitivity, specificity, or treatment recommendation can be inferred from the total.
  • A negative or indeterminate CMR does not independently exclude myocarditis; timing, protocol, image quality, and pre-test probability matter.
  • Urgent clinical assessment is required for hemodynamic instability, significant ventricular arrhythmia, high-grade AV block, acute heart failure, or other signs of severe disease.

References

Ferreira VM, et al.Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J Am Coll Cardiol. 2018;72:3158–3176. doi:10.1016/j.jacc.2018.09.072; PMID: 30545455.
Williams MGL, et al.Peak Troponin and CMR to Guide Management in Suspected ACS and Nonobstructive Coronary Arteries. JACC Cardiovasc Imaging. 2022. The reported 94% CMR diagnostic yield applied to a specific cohort with suspected ACS and nonobstructive coronary arteries, peak troponin T ≥211 ng/L, and CMR within 14 days; it is not a SARS-CoV-2 myocarditis probability estimate. doi:10.1016/j.jcmg.2022.03.017.
Ferreira VM, et al.Diagnostic Accuracy of Cardiovascular Magnetic Resonance in Acute Myocarditis: A Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging. 2018. doi:10.1016/j.jcmg.2017.12.008.
Clinical disclaimer: This page is an educational aid. The scoring weights and categories are not validated for diagnosing SARS-CoV-2–related myocarditis and should not guide treatment or disposition. Apply current local protocols and specialist clinical judgement. CMR findings support assessment of myocardial inflammation but do not independently establish its etiology.